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Abstract 
Medication prescription rankings and demands prediction could benefit both 
medication consumers and pharmaceutical companies from various aspects. Our study 
predicts the medication prescription rankings focusing on patients’ medication switch 
and combination behavior, which is an innovative genre of medication knowledge that 
could be learned from unstructured patient generated contents. We first construct two 
supervised machine learning systems for medication references identification and 
medication relations classification from unstructured patient’s reviews. We further map 
the medication switch and combination relations into directed and undirected networks 
respectively. An adjusted transition in and out (ATIO) system is proposed for 
medication prescription rankings prediction. The proposed system demonstrates the 
highest positive correlation with actual medication prescription amounts comparing to 
other network-based measures. In order to predict the prescription demand changes, 
we compare four predictive regression models. The model incorporated the network-
based measure from ATIO system as one of the predictors achieve the lowest mean 
squared errors. 
Keywords:  Data mining, Prescription rankings prediction, Medication relation network, 
Text mining, Medication switch, Medication combination 
Introduction 
Medication prescription forecasting allows predicting future medication demands. It is one important 
process of medication planning by influencing future supply of medication and related products (Sekhri et 
al. 2006). Accurate medication prescription predictions benefit not only pharmaceutical companies but 
also general users for whom such information is critical but difficult to gain. To evaluate the competition 
and the most profitable products by obtaining medication prescription rankings and changes over time, 
pharmaceutical companies usually invest a huge amount of money to hire analysts manually acquiring 
such information from institutions or medication users. For medication users, the medication rankings 
could shed light on the effectiveness of alternative medications. With this information, patients could 
identify the most widely used medications. To predict the medication prescription, prior research mainly 
focuses on using historical prescription information (El-Iskandarani et al. 2013 and Ghousi et al. 2012) 
and patient information (Rose et al. 1985) without considering the influence of relations among 
medications. Our study, instead, forecasts prescription rankings and demands from a novel aspect by 
concentrating on two types of medication relations: medication switch and combination, and exploring 
their predictive utilities for forecasting prescription rankings and future demands.  
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Medication switch refers to the changing of one brand-name product to another, a brand-name product to 
a generic medication, or a generic medication to the same product produced by different manufacturers 
(Furberg et al. 2010). This is usually determined by both patients and their physicians. Based on user 
generated content, patients could require a medication switch due to severe side effects or inefficacy. Then 
physicians would change their prescriptions according to the feedback. The medication combination 
refers to two or more active pharmaceutical ingredients (APIs) combined in a single dosage form (Adams 
et al. 2015). Changes of medication prescription amounts could be partially result from the altering of 
patients’ medication combining and switching behavior. If more patients switch from other brands to this 
focal one than patients switch away, this focal medication would receive more prescription demands and 
better prescription ranking. In addition, high consumption of one medication could serve as an important 
signal for the increase of prescription demands of its combination medications.  
Nevertheless, complete real life medication transition and combination data is difficult to collect. The 
direct method to retrieve medication relations is to query patients for their medication prescription 
history from a general population, which is very expensive. On the other hand, with the number of health 
care related social networks increasing rapidly these years, people are more likely to read, communicate 
or report their health condition, disease or medication usage experience on different websites such as 
personal blogs, health related forums, health product reviews, personal microblogs or tweets (Ventola 
2014). The user generated data, alternatively, which contain abundant detailed medication relation 
information, could be analyzed manually or automatically for medication relations extraction. As 
demonstrated in Figure 1, besides the focal medication experience, they also discussed additional 
medication involvements. Under the discussions from WebMD 1  of focal medication “Xanax”, a few 
sentences of reviews could be extracted “The combo of Lexapro and Xanax has…” and “I tried valium, 
buspar and klonopin and …, after trying Xanax …”. The two sentences represent two types of medication 
relations. The first sentence demonstrates a medication combination relation which indicates the 
medication “Xanax” and medication “Lexapro” are taking together by the same patient in a single dosage 
form. The second sentence displays a transition relation which demonstrates the sequence of medications 
taken by patients. In this case, patient was first on medication “Valium”, “Buspar” and “Klonopin”, but 
due to the ineffectiveness, he or she switched from these three medications to “Xanax”. The switch from 
one medication to another and combination relations revealed in patients’ review could reflect their 
honest medication switching and combination behavior in real life. 
Comment 1: The constant anxiety was destroying 
my life. The combo of Lexapro and Xanax has 
made me feel better than I have in years. I’ve used 
it for four years and will continue using it.  
Comment 2: This is exactly what I needed. After 
being discharged from the army I began having 
severe anxiety and frequent panic attacks. I tried 
valium, busapr and klonopin and none of them 
worked. After trying Xanax I finally felt normal. 
Figure 1. Medication Transition and Combination Example 
In order to predict prescription rankings and demands with medication relations, our study, therefore, 
extracts medication transition and combination relations from patients’ generated contents that could 
reflect their actual common switching and combining actions in general. Two supervised machine 
learning systems are proposed for medication identification and relationship extraction from user 
generated content. The medication relations are further mapped into medication relation network (MRN). 
We then propose a novel adjusted transition in and out (ATIO) system with MRN-based measures for 
prescription rankings prediction. The machine learning systems and proposed transition system are built 
and evaluated with real-world medication reviews and prescription data. 
Our study is different from the prior social network based medication learning studies from several 
aspects. First, comparing to the Adverse Drug Reactions (ADRs) extraction and detection studies (Leaman 
et al. 2010 and Liu et. al 2014) that focus on the adverse effects of one focal medication, our study not only 
emphasize on the focal medication that is mainly discussed, but also highlight other medications present 
together with the focal one. Second, in contrast to medication comparison study (Adusumalli et al. 2015) 
that compares the effectiveness of medications treating similar symptom using pre-existing domain 
                                                             
1 WebMD is an online publisher of news and information pertaining to human health and well-being. (http://www.webmd.com ) 
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knowledge and user generated ratings, our study analyzes entire medication transition and combination 
relations based on the review and discussion contents. Third, even though the Drug-Drug Interactions 
(DDIs) detection studies (Van Puijenbroek et al. 1999 and Caster et al. 2010) analyze more than one 
medications at once, the purpose of these studies is to discover the interactive effects of the medications 
so as to complement current pharmacovigilance system. Our study instead retrieves medications 
occurring in the same discussion content, and further analyzes if they are switching from or taking 
together with each other. By discovering the transition and combination patterns, the main aim of our 
study is to forecast the medication prescription rankings and demand changes. 
The remainder of the paper is organized as follows. We first review related studies and highlight key 
differences between our study and representative previous research. We then formally propose two 
supervised machine learning systems for medication references (all medication names or references 
mentioned in the reviews) recognition and relationship extraction. Next, we propose ATIO system and use 
the system for medication prescription rankings prediction. Furthermore, we use medication reviews to 
build and evaluate two machine learning systems and the proposed ranking system, with several prevalent 
methods as benchmarks. Medication prescription demand changes are predicted as well with four 
regression models. We conclude the paper by discussing important contributions, implications, and 
limitations. 
Literature Review 
Several streams of research are relevant to our study, including user generated contents mining for 
medication related knowledge learning, product network extraction from user generated contents and 
medication demands prediction. In this section, we review representative studies in each stream and 
highlight the gaps that motivate our research.    
Medication Related Knowledge Learning from User Generated Contents  
Prior studies take the benefit of large volume user generated data on social media and make it a useful 
resource for ADRs detection (Leaman et al. 2010 and Liu et. al 2014), DDIs identification (Van 
Puijenbroek et al. 1999 and Caster et al. 2010) and medication comparison (Adusumalli et al. 2015).  
ADRs refer to injuries caused by taking medication (Edwards and Aronson 2000). They are caused by 
single medication dose or the combination of two or more medications. Comparing to other areas, due to 
the severity of possible ADRs, ADRs detection and analysis has drawn great attention from both academia 
and industry. Social media that both health-related such as, MedHelp (Liu et. al 2014 and Yang et al. 
2014), DailyStrength (Leaman et al. 2010 and Yeleswarapu et al. 2014), and general social media such as 
Twitter (Ginn et al. 2014 and Bian et al. 2012) are used for ADRs learning. In terms of extraction method, 
both supervised and un-supervised machine learning systems are adopted for concept extraction, drug 
classification and ADRs classification. Lexicon-based, pattern-based, association rule and parsing tree are 
the most commonly employed un-supervised learning methods. Leaman et al. (2010) and Nikfarjam and 
Gonzalez (2011) both employ lexicon-based system development and pattern-matching to identify 
patterns. Association rule mining is utilized to identify ADR pairs by Yang et al. (2012). Yates and 
Goharian (2013) first develop about 7 patterns of ADR relationship and adopt these patterns to extract 
ADRs from estimated 125 manually annotated comments. Parsing tree is used to extract dependency 
relations between words. Liu and Chen (2013) apply parsing tree and discover the shortest dependency 
path between drug and its adverse reaction, therefore identify the drug-reaction pairs relation. Supervised 
learning methods on the other hand, are built depending on data annotations. Bian et al. (2012) construct 
two Support Vector Machine (SVM) classifiers. The two classifiers are used for classifying if patients use 
the medication and if the review post contains an ADR respectively. Besides SVM, maximum entropy 
classifier is trained on annotated 600 tweets and another 285 tweets are used for testing by Jiang and 
Zheng (2013). Yang et al. (2013) combine supervised and unsupervised approaches. For supervised 
learning, they train both SVM and naïve Bayes classification models with sentiment features as predictors.  
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DDIs refer to the activity of a drug is affected by a substance (another drug) when both of them are 
administered together (National Prescribing Service 20092). Since DDIs and ADRs detection are both 
important for drug safety surveillance, DDIs detection from unstructured user generated contents has 
been widely studied as well. Supervised and un-supervised high dimensional models such as multivariate 
logistic regression, the shrinkage measure, multiplicative model and association rule learning are 
employed for DDIs identification. Van Puijenbroek et al. (1999) propose multivariate logistic regression 
for retrospective detection of DDIs with FDA Substance Registration System (SRS) database. They 
discover the potential association between delay of withdrawal bleeding during concomitant use of oral 
contraceptives (OCs) and antifungal Iitraconazole (I). Similarly, Bayesian logistic regression is utilized by 
Caster et al. (2010) to address the “masking effect”, which is the increase in background could not 
attenuate values of true association. Norén et al. (2008) propose the Shrinkage measure for recognizing 
drug interactions and improving the performance comparing to logistic regression, which sometimes miss 
important DDIs. Thakrar et al. (2007) compare the model performances of multiplicative model and 
additive model using existing known drug interactions. In terms of detecting performance, additive model 
has better sensitivity than multiplicative model. Unsupervised learning technique such as association rule 
learning has been used to draw inferences of hidden relations as well. Harpaz et al. (2010) employ Apriori 
algorithm based association rule to mine a sample of FDA Adverse Event Reporting System (AERS). At 
least two medications and one adverse effect as a rule are reported as a detection result.  
Due to limited contribution to pharmacovigilance, few studies have extracted multiple medications and 
their relations from unstructured user generated contents. Adusumalli et al. (2015) compare the 
effectiveness of medications treating similar symptom by numeric user generated rating from WebMD. 
The categorization of medication comparison pairs is depending on medication targets learned from the 
prior domain knowledge. The comparison of effectiveness then further be evaluated by counted results 
from prior literature. Even though a small portion of pairs (77 out of the 427) are discovered in prior 
studies, approximately two thirds of the trends are supported.  
Comparative, Competitive Opinions and Cooperative Intelligence Learning from 
User Generated Contents  
Limited studies have concentrated on multiple medications comparison on the basis of unstructured text 
contents. In terms of business realm, although majority of studies focus on investigating opinions towards 
a single entity (e.g. a product), there are a few studies available aiming at discovering competitive and 
comparative opinions, as well as cooperative intelligence among various products mentioned together. We 
elaborate the representative studies in detail.  
On the cooperative intelligence front, Dhar et al. (2014) define an economic network based on customer’s 
co-purchasing behaviour. The aggregated network measures such as PageRank and Cluster are employed 
as features for prediction models, which are used for future focal product demands prediction. 
In order to learn product competitive and comparative opinions, Netzer et al. (2012) apply text mining 
methods to build graphs based on co-occurrence of product name entities from sedan and diabetic drug 
forum messages. They link sedan product name entities with undirected link and construct undirected 
graph. The graph is further employed for sedan market structure and competition analysis. Based on the 
co-occurrence of products from same sentence, Xu et al. (2011) propose a sequence labelling conditional 
random field (CRF)-based model to extract comparative relations between products from each sentence of 
online customer reviews. Zhang et al. (2013) group product pairs with co-occurrence at message level and 
propose a polarity classifier giving sentiment scores for each product pair. The higher sentiment score for 
one product is comparatively better than the other one from the same product pair. They then construct a 
directed product network based on the comparative relations. PageRank and other network-based 
measures are adopted for product rankings prediction and market structure mapping.  
                                                             
2 National Prescribing Service 2009 is available at http://www.nps.org.au/media-centre/media-releases. 
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Pharmaceutical Medication Demands Prediction  
To predict medication prescription changes in the future, understanding the factors that influence the 
medication demands is essential. Similar to product demands, the demands for pharmaceutical 
medication are affected by numerous aspects. Manufacture’s marketing strategy, such as Direct-to-
Consumer advertising (Donohue et al. 2007), is associated with significant growth in sales for different 
classes of medication. Other factors such as physician and patient incentives (Dickstein 2011), seasonal 
and epidemic disease, market share of competitive products and active ingredient ratio (Galarraga et al. 
2007) are considered as main predictors for forecasting medication demands.  
Forecasting revenue potential and driving a number of tactical and strategic decisions are valuable for 
pharmaceutical companies, but it is extremely difficult to make accurate predictions. In order to forecast 
the demands of medication, the most straightforward approach is to collect report data from World 
Health Organization (WHO). According to forecasts of global and regional demand report, the future 
demands of medications are determined on the basis of important variables such as total number of 
people receiving the therapy and the number of person-years of treatment. Then they utilize three 
forecasting models linear regression, country target model and Clinton health access initiative to predict 
demands of therapy and antiretroviral medicines in year 2012-2015. On the other hand, historical 
demand data could be used for forecasting the future medication consumption. El-Iskandarani et al. 
(2013) propose a temporal pattern matching algorithm. By discovering the most similar consumption 
patterns of medication in the past, they could predict the patterns in the future. Ghousi et al. (2012) 
compare different machine learning predictive algorithms such as regression, artificial neural network 
(ANN) and decision tree with historical report of medication distribution and customers’ demography 
information. However, historical data could offer few guidelines for forecasting the future of a new 
medication or a medication in a new therapeutic category. Instead of depending on historical prescription 
data, Rose et al. (1985) forecast the future medication prescription demands by estimating the number of 
future patients by incorporating potential new patient population and original continuing patients. 
Research Gap Summary  
As we discussed in the introduction, discovering the pattern of medication transition and combination is 
important for competition recognition and demands forecasting. Comparing to the current studies which 
mainly focus on extracting ADRs and DDIs from social networks that contribute to pharmacovigilance, we 
explore a new realm of study that pay attention to obtain multiple medications, categorize their relations 
and map the relations to a network for prescription prediction. In contrast to medication effectiveness 
comparison learning (Adusumalli et al. 2015), we do not pre-group certain medications together as pairs 
using domain knowledge and only compare pairs. On the other hand, besides numeric general ratings, we 
extract and learn unstructured review text with detailed medication combination and transition patterns. 
The key differences between our study and prior social network medication learning studies are 
summarized in Table 1.  
Study Focus Level Analysis Level Purpose Implication 
ADRs 
detection 
Focal 
mediation only 
User generated 
message 
ADRs extraction and 
analysis 
Pharmacovigilance 
DDIs 
detection 
Multiple 
medications 
User generated 
message 
DDIs extraction and 
analysis 
Pharmacovigilance 
Effectiveness 
comparison 
Multiple 
medications 
Multiple user 
generated messages 
and ratings 
Compare the 
effectiveness of 
medication pairs with 
same target 
Medication 
selection 
Current 
study 
Multiple 
medications 
User generated 
message 
Medication relations 
extraction and 
categorization 
Competition 
recognition and 
demand prediction 
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Table 1. A Brief Summary of Medication Learning Related Studies 
Furthermore, prior product network studies emphasize on extracting main comparative, competitive or 
cooperative relations among product entities. They utilize customer co-purchasing records (Dhar et al 
2014) for mining cooperative relations and co-occurrence with sentiment analysis for identifying 
comparative entities (Netzer et al. 2012, Xu et al. 2011 and Zhang et al. 2013). Our study, not only detects 
medication co-purchasing relation, which is considered as medication combination, but also further 
discovers the latent medication switch sequences and transition patterns. Medication switch is not exactly 
equivalent to medication comparison. Patients do not necessarily compare switch from medication with 
focal medication or switch to medication in their posts. When users make comparison between two 
products, these two products might not be consumed sequentially and users might use both of them at the 
same time. In addition, prior studies either map a directed or undirected entity network for product 
relation analysis. Our study constructs both undirected and directed networks based on medication 
combination and transition relations respectively. The major differences between our study and prior 
product comparison studies are summarized in Table 2. 
Study Focal Problem Analysis Level Network Perspective 
Dhar et al 2014 Entities co-purchasing Purchasing records Directed links and nodes 
Netzer et al. 
2012 
Entities comparison Each message from posts Undirected links and 
nodes  
Xu et al. 2011 Entities comparison Each sentence from 
messages 
Directed links 
Zhang et al. 
2013 
Entities comparison Each message from posts Directed links and nodes 
Current Study Entities transition and 
combination 
Each message from posts Undirected links, directed 
links and nodes 
Table 2. A Brief Summary of Product Comparison Related Studies 
Last but not the least, majority of the medication demand forecasting studies rely on historical demand 
and patient data for certain medication and employ machine learning algorithms such as regression, ANN 
and decision tree for future demand prediction. Besides historical demands, factors such as manufacture’s 
marketing strategy (Donohue et al. 2007), physician and patient incentives (Dickstein 2011), seasonal and 
epidemic disease, market share of competitive products and active ingredient ratio (Galarraga et al. 2007) 
that essentially influence the demand are difficult to access in real world. Our study, without fully 
depending on detailed historical prescription and patient data, obtain predictors from unstructured user 
generated discussion. Through learning medication transition and combination relations, the market 
structures for competitive and cooperative products could be estimated and utilized for prescription 
demands and rankings prediction.  
Research Design 
In this section, we first propose two supervised SVM systems for medication reference identification and 
medication relation classification. The medication relations are further transformed to the medication 
relation network (MRN). A novel ranking system ATIO using MRN-based measures is proposed for 
medication prescription rankings prediction. 
Medication Reference Identification and Relation Classification  
To explore the medication transition and combination patterns, we identify medication references from 
unstructured patients’ review, and then categorize medication references into different classes. First of all, 
the phrases that refer to the medication that is currently being reviewed and mainly discussed are 
categorized into CurrentMed (CM) class. For the review sentence “I really do not like to take Prednisone 
unless I absolutely have to”, “Prednisone” is regarded as CM. There are different reasons why users refer 
to other medications in their generated reviews. Users could mention the medication in their generated 
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reviews and stated they previously took it before starting on the CM. We then categorize this type of 
medication references into SwitchFromMed (SFM) class. For the review sentence “I didn’t walk for 6 
months, even with Methotrexate, I finally found a smart Dr. who prescribed me Prednisone”, 
“Methotrexate” is considered as SFM of the CM “prednisone”. Furthermore, users might also mention the 
medications they plan to take in the future or already started to take after they stopping on the CM. This 
type of medication references is categorized into SwitchToMed (STM) class. For example, for review 
sentence “Only took for one week, then back to Ibuprophen”, “Ibuprophen” is the STM of the CM. In 
addition, some medications are mentioned by users in their reviews together with the CM to treat the side 
effect caused by CM, relieve other symptoms or use as a supplement to enhance the treatment power of 
CM. This type of medications belongs to TakeCombineMed (TCM) class. Take a review sentence “I also 
take Asacol and Remicade” as an example, “Asacol” and “Remicade” are both TCMs for the CM. If the 
medication references that do not fall into any categories above, we categorize this type of medications as 
Other Medication (OM). The medication transition pattern, therefore, could be recognized as starting 
from SFM to CM, then ending at STM. The medications belong to CM and TCM classes are medication 
combination.  
In order to identify different medication references and classify the relation types for reviewed 
medications, we applied two stage system on the extracted reviews. Identification of medication 
references is the first stage and classification of the medication references into the above mentioned five 
classes is the second stage. 
Extracting all the medication references from the raw text is challenging. Two approaches are employed to 
identify the medication references. One basic approach is to take advantage of the available tools such as 
MedEX (Xu et al. 2010) to recognize the medication names from the raw reviews. Besides the MedEx, we 
further develop our medication identification system. Our system treats each word in the reviews as 
medication reference candidate. Then we employ SVM binary classifier to identify if these words are 
medication references or not. The features used for classification model building include the word feature, 
Part-Of-Speech (POS) tags feature, the prefix. The full feature list is presented in Table 3.  
Feature Name Description 
Word Type Current word 
Part-Of-Speech The POS of the current word 
Morphology The suffix and prefix of the current word 
Lemma The lemma of current word 
MedEX Tag The semantic tag assigned by the MedEX 
Table 3. Features for Medication Reference Identification Model 
A medication relation classification system is employed to recognize the relations between medication 
references by classifying them into five classes: STM, SFM, TCM, CM and OM. After identifying all the 
medication references in the reviews, these references then be categorized with relation classification 
system. The relation classification system consists of five binary classification models with each binary 
classifier identifying one medication relation class. These classifiers are trained on the manually 
annotated data with medication class labels. For each binary classifier, we regard all the medication 
references that belong to the certain medication relation class as positive training examples, and the rest 
of references are considered as negative training examples. We apply linear SVM classifier as well to 
construct the five classifiers. The features for the five classifiers are presented in Table 4. 
Feature Name Description 
BOW Bag of words as features; window size is 5.  
POS POS of surrounding words, window size is 2 
Bigram Bigram features, window size is 3 
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Dependency The dependency relations with current word 
Table 4. Features for Medication Reference Classification Model 
MRN  
In order to rank medication prescription demands with the extracted medication relations, we define two 
types of network: directed and undirected to map the relations among medications. The three major 
relations of medications: switching from the focal medication to another, switching from other medication 
to the focal medication, and taking other medication combine with the focal medication could be 
illustrated in directed and undirected networks. 
Switch from One Medication to Another Medication 
We demonstrate the “switch from x to y” relation of medications in a directed graph M, with each node 
representing one distinct medication and one directed edge corresponding to the switching relation 
between two medications. For example, we extract the relation between medications “Risperdal” and 
“Geodon” from one patient’s review indicating the patient was first prescribed “Risperdal” and then 
changed to “Geodon”. We show this switching relation in a directed graph with “Risperdal” and “Geodon” 
as two nodes and a directed edge from “Risperdal” pointing to “Geodon”. On the other hand, if patient 
mentioned he/she is taking “Xanax” after stopping on “Pristiq”, the directed edge would start from 
“Pristiq” pointing to “Xanax”. 
 
Figure 2. Switch Medications from One to Another 
Combine One Medication with Another Medication  
We also demonstrate the “taking x together with y” relation of medications in an undirected graph N, with 
each node representing one distinct medication and one undirected edge corresponding to the 
combination relation between two medications. For example, we extract the relation between medications 
“Cymbalta” and “Geodon” from one patient’s review indicating the patient was taking prescriptions 
“Cymbalta” and “Geodon” at the same time. We display this combination relation in an undirected graph 
with “Cymbalta” and “Geodon” as two nodes and an undirected edge connecting these nodes shown in 
Figure 3. 
 
Figure 3. Combined Medications  
Convert Undirected Network to Directed Network  
We then convert all undirected edges from N to directed edges in order to combine all medications in one 
directed network S. We transform undirected edges to directed edges by replacing undirected edges with 
bidirectional links (Brams et al. 2006). For example, we substitute the undirected edge between nodes 
“Geodon” and “Cymbalta” by two directed edges both linking from “Geodon” pointing to “Cymbalta” and 
linking from “Cymbalta” pointing to “Geodon” shown in Figure 4. 
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Figure 4. Convert Undirected Graph to Directed Graph 
Rank Medication Prescription Demands  
To rank medication prescription demands based on medication transition and combination network, we 
first transform the network to a transition frequency matrix, a transition probability matrix and a Markov 
transition matrix. We then further propose an ATIO system. The prescription demand rankings are based 
on the difference of transition in and out for each medication.  
Construct a Matrix with MRN  
We draw the medications network S by combining network M and N using the medication relations 
extracted from the reviews. The network then are transformed into a transition frequency matrix  with 
each element in the matrix defined as .   is the frequency of directed edge from node  to  (,  ∈ 	). 
	 is the collection of all extracted medication references. For example, two patients mentioned switching 
medication “Xanax” to medication “Pristiq” in their reviews and one patient mentioned taking “Pristiq” 
after stopping on “Xanax”. Therefore, the elements corresponding to the relation between medication 
“Xanax” and medication “Pristiq” in the matrix  are: 

  1 and 

  2. Based 
on the frequency matrix , we then compute the transition probability for each pair of medications using 
Equation (1) (Shin et al. 2014).  
 


      (1) 
  is the frequency of transitions from medication   to medication  , while   is the frequency of 
transitions from medication   to medication  . Therefore,   is the probability of transition from 
medication  to medication  among the total transitions between the medication pair 	and . We set   0 
to ensure that  
"

  even when   	  0.  
Image medications “Xanax”, “Zoloft” and “Wellbutrin” having the transition relations shown in Figure 5.  
 
Figure 5. Medication Transition Example 
When we use the above equation to compute transition probability and assume   1, we would gain 

#
$%&%' 
"

, 
$%&%'
# 
"

, 
$%&%'
()&&*+ 
"

 and 
()&&*+
$%&%' 
"

. We observe that 
“Zoloft” could switch to two available medications in Figure 5, while there is only one available medication 
“Xanax” and “Wellbutrin” could switch to. However, the transition probability for the three medications 
turn to be equal based on our transition probability (1). In order to distinguish the weight of directed 
edges for medications like “Xanax” and “Zoloft”, we introduced , to adjust the weight. , is the number of 
out-degree edges of node . Out-degree edges refer to the edges that transit away from the focal node. In 
addition,   is the probability of node  pointing to node . Parameter γ. allows the sum of  total transition 
probability from  to all other medications to be 1 . / is the element in adjacency matrix of the network  
with /  1 if and only if the edge 
,  ∈ 	. Hence, the Markov transition probability matrix 0 could be 
presented in equation (2): 
1  	γ. ∙ 	 ∙ / 3	,
4"      (2) 
By multiplying   by  ,
4", and assuming   1, we will adjust the value of transition probability by the 
number of out-degree edges of node . Then we will gain 
#
$%&%' 3 ,5%&%'
4"  "
6
, 
$%&%'
# 3
,#4" 
"

, 
$%&%'
()&&*+ 3 ,()&&*+
4"  "

 and 
()&&*+
$%&%' 3 ,5%&%'
4"  "
6
. The transition 
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probabilities from “Zoloft” to other nodes would be reduced comparing to the probabilities without 
adjusted parameter ,
4". 
ATIO System  
Park et al. (2005) propose a win-lose system to rank the U.S. football teams with a contest network they 
constructed. We adapt their system and construct an adjusted transition in and out system to calculate the 
medication transitions. 
For a certain medication , direct medication prescription transition probability towards medication  
from medication  is 1 . If there are in total 7 different medications switching to medication , the total 
direct transition probability towards medication  could be calculated using 8 .  
8 	∑ 1  (3) 
For a certain medication  , indirect medication prescription transition towards medication   from 
medication ,  could be demonstrated in Figure 6. Medication k indirectly convert to medication   by 
directly switching to medication . The distance from medication , to medication  is 2, which is the 
number of edges from node k to node .  
 
Figure 6. Indirect Transition Example 
We define the indirect transition probability from node k to node  using :;. 
:;  < 3 =1 3 1;>	  (4) 
< is the single free parameter that weighted on indirect prescription transition. If there are in total ? 
different medications switching to medication   through medication  , the total indirect transition 
probability of medications that towards medication  with distance 2 could be calculated using :;.  
:;  		< 3 ∑ ∑ 
1 3 1;@;

    (5) 
For further remote indirect medication transition probability with longer distance towards medication , 
we could demonstrate them using equation (6) to (7). 
:A  	< 3 <; 3 ∑ 
1 3 1; 3 1;A;A   (6) 
… 
:C  	∏ <
C
 3 ∑ 
1 3 1; 3 1;A 3 …3 1C;A…C   (7) 
Therefore, total probability of medication prescription transition towards medication 	is shown as W.. It 
is the sum of all probabilities transition towards medication . 
W.  8 F 	:; F :A F⋯F :C  ∑ 1 F	< 3 ∑ ∑ =1 3 1;>
@
;

 F < 3 <; 3 ∑ =1 3 1; 3;A
1;A> F 	∏ <
C
 3 ∑ =1 3 1; 3 1;A 3 …3 1C>;A…C  ∑ =1 F < 3:> 3 1

   (8) 
Similarly, Total probability of medication prescription transition away from medication  is shown as H. I 
is the single free parameter that weighted on indirect prescription transition similar to <. 
L.  ∑ 1 F	I 3 ∑ ∑ 
1 3 1;
@
;

 F I 3 I; 3 ∑ 
1 3 1; 3 1A;;A F 	∏ I
C
 3 ∑ 
1 3 1; 3 1A; 3;A…C
…3 1C  ∑ =1 F I 3 H> 3 1  (9) 
The transition probability towards medication  is calculated as : and the transition probability away 
from medication  is presented as H. Therefore, the increasing number of prescription demands for one 
medication should be the difference between the number of prescriptions transiting into and the number 
of prescriptions transiting away from medication  . The growing demand of medication   could be 
estimated as K in equation (10).  
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K 
∑ 1 3 L F	∑ ∑ < 3 
1 3 1; 3 L;
@
;

 F ∑ < 3 <; 3 
1 3 1; 3 1;A 3 L;A;A F⋯F ∑ ∏ <
C
 3;A…C

1 3 1; 3 1;A 3 …3 1C 3 LC − H 3 N   (10) 
N is the total number of direct transitions away from medication  in the relation network. L is the total 
number of direct transitions between medication  and medication . Then the new estimated demand of 
prescription O
P for medication i would be represented as the sum of the total number of user generated 
reviews O for medication  and K shown in equation (11) 
O
P  O F K 	  (11) 
The estimation of medication prescription demand rankings would be based on the amount of  O
P for each 
medication 	
 ∈ 	 . We further employ PageRank (Page et al. 1999), weighted PageRank (Xing et al. 
2004) and other measures for medication prescription rankings estimation.  
Obtain the Parameters α and β  
Parameters <  and β  are free parameters that weighted on indirect prescription transition. More 
specifically, < is the weight on indirect prescription transition towards medication and β is the weight on 
indirected prescription transition away from medication. Park et al. (2005) compute the indirect 
transition weight using the mean and mean square of total number of all edges in the network. We on the 
other hand, intend to distinguish the weight of different nodes in the network by their centralities. Our 
method assumes medications transit to a medication with higher centrality would have larger possibility 
transiting to more new medications. Adjusted eigenvector centrality is applied and adapted to compute 
the parameters < and β, or approximate importance, of each node in the network. Specifically, we allow 
<  	 3 < 	 and 	I  	 3 I. < is the weight on indirect prescription transition towards medication  
and I is the weight on indirect prescription transition away from medication .  
Empirical Study  
In this section, we elaborate how we acquired and annotated patient generated reviews for medication 
reference identification and medication relation classification models building and evaluation. Reviews of 
medication from one specific category were extracted additionally and utilized for MRN mapping and 
ATIO system learning. The rating prediction performance was evaluated with real medication prescription 
data. In the end, four predictive regression models were constructed for prescription demands prediction.  
Data Acquisition  
In order to develop and evaluate supervised SVM models for medication reference identification and 
relation classification, labelled data is necessary for model building. We therefore firstly collected 
medication review webpages and annotated them. We applied a crawler (Httrack 3 ) to crawl the 
medication review webpages from WebMD website. We then utilized Stanford coreNLP tool4 to conduct 
the tokenization and sentence splitting for each online medication review. Brat5 was employed to label the 
text annotations. Applying the brat for structured annotation, non-structured free form text would be 
transformed into a fixed form. Then the fixed form could be processed and interpreted by a computer 
program. 
Totally we crawled and received 75,312 medication user generated reviews of more than 50 medications 
from year 2007 to year 2015. Reviews have been all extracted from raw html. We contained five different 
fields including the condition the medication was utilized to treat, the date when the review was posted, 
                                                             
3 Httrack is an offline browser utility. It allows users to download a World Wide Web site from the Internet to a local directory, 
building recursively all directories, getting HTML, images, and other files from the server.( https://www.httrack.com) 
4 Stanford CoreNLP provides a set of natural language analysis tools. They could analyze the structure of the sentences, give the base 
forms of words, part of speech, entity recognition and so on. (http://stanfordnlp.github.io/CoreNLP/ ) 
5 Brat is a web-based tool for adding notes to existing text documents. (http://brat.nlplab.org) 
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patient’s information such as age, gender, treatment time (how long they have been on this medication), 
the ratings according to the effectiveness, ease of usage and satisfaction and the review contents of each 
medication review the patient wrote for the medication. Amongst these 75,312 reviews, we selected 200 
reviews from various medications and trained two of our team members to manually annotate the 
reviews. There are five different types of medication relations we tagged that discussed above and mainly 
reflected in the reviews. The medication that mainly discussed by patients in the current review is tagged 
as CM. The relation types of other medication references are tagged as SFM, STM, TCM and OM. The rest 
reviews were used for example demonstration of medication relations after the models were built. Due to 
the page limit, we did not include the demonstration section in this study. 
To build the prescription ranking system, we need to construct a transition and combination network with 
a category of medications that frequently transit to or combine with each other. Therefore, we selected 27 
psychiatric medications that targeting at 5 main mental illness categories as a demonstration. In total we 
crawled additional 36,245 reviews for these 27 psychiatric medications. To evaluate the ranking system, 
actual prescription demand rankings and prescription quantities for psychiatric medications were 
gathered from IMS Health6. We obtained psychiatric medications prescription rankings and quantities 
from year 2009, year 2011 and year 2013.  
Evaluation of Medication Recognition and Relation Classification  
We evaluated our systems on the manually annotated dataset. To fully utilize our human annotated 
reviews, we employed 10-fold cross validation (Geisser 1993) for both medication reference recognition 
and relation classification tasks. To assess the performance, we employed precision, recall and F-measure 
(Van Rijsbergen 1979) as our evaluation metrics. Our medication identification model employed the 
word-type, POS, morphology, lemma, MedEX tag as features. The results are presented in Table 5. We 
also employed and reported the MedEx as a benchmark technique on our dataset for identification task. 
MedEx is the rule based medication extraction system. Comparing to this rule based model, our system 
outperformed the benchmark method in terms of precision, recall and F-measure. Comparing the 
extraction results fetched from the two systems, we discovered the main issue of MedEX is that they failed 
to discover the pronouns, if the pronouns refer to medications. In the meantime, our system did fairly well 
on the prediction of pronouns.  
Method Precision Recall F-Measure 
MedEX 65.7 24.0 65.7 
OurSystem 84.3 73.6 78.6 
Table 5. Medication Reference Recognition Results 
The medication relation classification results are presented in Table 6. Since there are no other systems 
that have explored this task. We do not have any available benchmarks to compare with but ourselves. 
Therefore, we evaluated our system with various feature collections. The first collection included basic 
features (BOW features) and then the rich features included bigram features, POS tagging and 
dependency. Comparing the results from two collections of feature, rich features did not improve the 
system performance much. One possible reason is data sparsity problem. The number of instances in the 
training sample is limited. Hence, more features might lead to more severe sparsity problem.  
 CM TCM SFM Average 
Basic Features 77/81/78 51/28/36 13/4/6 73/64/68 
Rich Features 78/81/79 52/31/39 20/4/6 73/64/68 
                                                             
6 IMS Health is a company that provides information, services and technology for the healthcare industry. It is the largest vendor of 
U.S. physician prescribing data. (http://www.imshealth.com ) 
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Table 6. Medication Classification Results, Results are shown as Precision/Recall/F 
measure. CM, TCM and SFM refers to current medication, take combine medication and 
switch from medication7 
Evaluation of Medication Prescription Rankings Prediction 
In order to extract the MRN for prescription rankings prediction, the prior trained medication reference 
identification model was utilized to recognize psychiatric medication references from each sentence of 
36,245 reviews. The trained medication relation classification model was then applied to classify the 
relations among the 27 medications. 
The medication reviews written ranging from year 2007 to year 2008 were crawled and the relations 
among medications were mapped to predict the ranks of prescriptions in year 2009. Similarly, reviews 
written ranging from year 2007 to year 2010 were employed to predict the ranks in 2011 and reviews from 
year 2007 to year 2012 were engaged to predict the prescription ranks in 2013.  
We further constructed three MRNs on the basis of psychiatric medication relations extracted from 
reviews before year 2009, 2011 and 2013. Three frequency matrixes and three Markov transition 
probabilities matrixes for different years according to the networks were then developed. We further 
computed and ranked the transition differences of each medication employing ATIO system for year 
2009, 2011 and 2013. In addition, network-based measures such as PageRank, weighted PageRank, the 
authority score (instead of hub score, due to the transition nature of the medication) from Hyperlink-
Induced Topic Search (HITS) (Kleinberg 1999) were constructed for rankings prediction. We then 
transformed our directed MRN to undirected network by treating directed edges as undirected edges. 
Betweenness centrality (Freeman 1977) was computed for the undirected network. Higher centrality 
measurements indicate higher importance of the position of the medication. The volume of the 
medication discussions, known as the number of reviews for each analyzed medication, could serve as an 
important measurement for rankings comparison. Larger volumes of medication reviews demonstrate the 
general larger number of discussions associated with the medication, which could also represent the 
prescription amounts. The above mentioned measurements including PageRank, weighted PageRank, the 
authority score, Betweenness centrality and number of reviews are served as benchmark methods in our 
study. 
We therefore, compared the predicted rankings performance with true rankings of the psychiatric 
medications in year 2009, 2011 and 2013 with Kendall’s rank correlation tau (Kendall 1938) and 
Spearman’s rank correlation rho (Spearman 1904) in Table 7. 
Method Direction 
Setting 
Kendall’s rank correlation tau  
(Year 2009/2011/2013) 
Spearman’s rank correlation 
rho 
(Year 2009/2011/2013) 
ATIO Directed Graph -0.2267/-0.3406**/-0.336** -0.3615*/-0.5304**/-0.4911** 
PageRank Directed Graph -0.0867/-0.3478**/-0.3281** -0.1946/-0.4817**/-0.4486 ** 
Weighted 
PageRank 
Directed Graph -0.14/-0.3406**/-0.3123** -0.2408/-0.5374**/-0.4773** 
HITS Authority Directed Graph -0.1177/-0.362**/-0.3447** -0.2198/-0.4972**/-0.4658** 
Betweenness 
Centrality 
Undirected 
Graph 
-0.1/-0.2899**/-0.2727** -0.1762/-0.3965*/-0.3844* 
NumReview 
(Volume) 
No Graph -0.2133/-0.3768***/-
0.4071*** 
-0.3338/-0.533***/-
0.5326*** 
                                                             
7 Due to the limited number of STM, we only presented the evaluation results for the three medication classes. 
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Table 7. Univariate Rank Correlation with Prescription Rank in 2009, 2011 and 2013 (* 
p<0.1, ** p<0.05 and *** p<0.01) 
Due to the ranking nature of the prescriptions, a smaller rank value implies larger prescription amount. If 
the correlation measure is negative, the indicated predictor has a positive influence on the actual 
prescription quantities.  
As we can observe from the correlation results, measurements calculated by PageRank, weighted 
PageRank and HITS authority demonstrate significant negative correlation with Kendall’s τ from -0.3123 
to -0.362 and Spearman’s ρ from -0.4486 to -0.5326 for prescription rankings of year 2011 and year 2013. 
Betweenness centrality measures that computed on the undirected network also indicate a strong negative 
correlation with prescription rankings of year 2011 and year 2013. The volume of the reviews plays an 
important role in predicting the medication prescription rankings with Kendall’s τ from -0.2133, -0.3768 
to -0.4071 and Spearman’s ρ from -0.3338, -0.533 to -0.5326 for year 2009, 2011 and 2013 respectively. 
With moderate number of reviews for medication before year 2009, PageRank, weighted PageRank, HITS 
authority, centrality measurement and volume of reviews fail to demonstrate their significant correlations 
with actual prescription rankings. Our proposed ATIO system presents the strongest negative correlation 
with prescription rankings for year 2009 with Kendall’s τ equals to -0.2267 and Spearman’s ρ equals to -
0.3615.  
For year 2013 and 2011, non-graph benchmark method number of reviews achieves close and lower rank 
correlation than our proposed method. It is reasonable that the volume number of reviews indicates the 
medication prescription amounts. Increasing prescriptions from physicians could result in increasing 
number of patients, which would reflect in increasing number of patients leaving reviews on various social 
medias. There are two possible reasons that number of reviews receives lower Kendall’s τ and Spearman’s 
ρ than our method. Firstly, the experimental results are based on the reviews crawled from single social 
media WebMD. Inadequate review variety would negatively affect the performance of our proposed 
method, since single review source might be biased towards certain medication than others. Secondly, 
since we used reviews to predict aggregated yearly prescription rankings in our experiment, yearly 
rankings with aggregated large amount of reviews would whittle down the advantages of our method. 
With moderate amount of reviews, our proposed method performs best comparing to all benchmark 
methods. For example, to predict prescription rankings for year 2009, the medication network structure 
was based on reviews only from 2007 and 2008 and our method outperformed all other methods for 
prescription rankings prediction in 2009. 
Overall, our proposed system achieves the strongest negative correlation with prescription rankings 
comparing to other network- based measures such as PageRank, weighted PageRank, HITS authority and 
Betweenness centrality for all three years. Moreover, with moderate number of reviews for medication 
before year 2009, ATIO method also demonstrates the significant negative correlation with the actual 
prescription rankings. 
Predictive Modeling and Results  
To further validate the predictive power of the MRN based ranking measures on top of existing 
medication review metrics in the literature, we build a set of prediction linear regression models. To 
demonstrate the predictive power, we apply variables from year 2007 to year 2008, from year 2007 to 
year 2010 and from year 2007 to year 2012 to predict the percentage of medication prescription changes 
for year 2009, year 2011 and 2013 respectively. We compare the model performances in terms of Mean 
Squared Error (MSE), R	and adjusted R. 
log
Prescription`  	α`4" F	β"NumReview`4" 	F 	βEaseofUse`4" F βlEffective`4" F	β6Satisfy`4" F o   (1) 
log
Prescription`  	α`4" F	β"NumReview`4" 	F 	βEaseofUse`4" F βlEffective`4" F	β6Satisfy`4" F
βplog	
NumTransition`4" F o       (2) 
log
Prescription`  	α`4" F	β"NumReview`4" 	F 	βEaseofUse`4" F βlEffective`4" F	β6Satisfy`4" F
βplog	
NumTransition`4" F 1rstRr7,4" F:tsℎvtw1rstRr7,4" F o        (3) 
log
Prescription`  	α`4" F	β"NumReview`4" 	F 	βEaseofUse`4" F βlEffective`4" F	β6Satisfy`4" F
βplog	
NumTransition`4" F 1rstRr7,4" F:tsℎvtw1rstRr7,4" F log	
K4" F o    (4) 
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Model Predictors MSE R Adjusted 
R 
F − stat	 
Signifance 
1 NumReview, EaseofUse, Effective, Satisfy 0.3114 0.4359 0.4022 <0.001 
2 NumReview, EaseofUse, Effective, Satisfy, 
NumTransition 
0.2994 0.4577 0.4166 <0.001 
3 NumReview, EaseofUse, Effective, Satisfy, 
NumTransition, PageRank, 
WeightedPageRank 
0.2749 0.4851 0.4279 <0.001 
4 NumReview, EaseofUse, Effective, Satisfy, 
NumTransition, PageRank, 
WeightedPageRank, TransitionProbability(G) 
0.2633 0.5068 0.4431 <0.001 
Table 8. Predictive Modeling Results 
The variables (predictors) included in Model 1 are number of reviews, ease of use, effective and 
satisfaction level of each medication. Number of reviews refers to the volume of reviews for each 
medication. Ease of use, effective and satisfaction level refer to the numeric ratings that are given by each 
customer on top of their review evaluating the medication from these three aspects, which are variables 
directly extracted from medication reviews. Each patient gave the ratings to the medication from three 
aspects and the variables used in Model 1 are the average rating scores for each medication. In terms of 
Model 2, we contained an additional predictor	yzs	
O{?|r7}vz7. NumTransition is the frequency of 
transitions from other medications to the focal medication, which is automatically counted after the 
extraction of medication relations by text mining techniques. For example, after preprocessing the reviews 
and conducting the medication identification and classification models, two patients in their reviews 
mentioned they switch their prescriptions from Valium to Xanax. Hence, the volume of NumTransition 
variable for medication Xanax is 2 according to the medication transition results. Furthermore, the 
predictors PageRank and weighted PageRank incorporated in the Model 3 are variables that computed 
based on the MRN. In the last model, K  is the estimated transition differences between certain 
medication’s transition in and transition out computed using ATIO system.  
We could observe that, when compared with the baseline model 1, the introduction of the NumTransition 
measure (model 2) resulted from the medication reference extraction and relation classification leads to a 
decrease in MSE and increase in both R	and adjusted 	R . The additional inclusion of MRN-based 
measures PageRank, weighted PageRank (model 3) further results in a decrease in MSE and 
improvements in both R	and adjusted 	R . By introducing the predictor that is from ATIO system 
yzs	
|r7}vz71|z~r~yv
K in the last model (model 4), we achieve the best model comparing to the 
prior models with least MSE and best R	and adjusted	R. We also conducted the overall F-test for four 
regression models with p value <0.001. Therefore, we could conclude that all the models provide better 
fits than the intercept-only model. 
Model Variables with Significant Coefficients 
1 NumReview*** 
2 NumReview ***, Satisfy* 
3 NumReview*, WeightedPageRank* 
4 NumReview*, Satisfy**, NumTransition*, WeightedPageRank*, TransitionProbability(G)* 
Table 9. Variables with Significant Coefficients (* p<0.1, ** p<0.05 and *** p<0.01) 
In Table 9, we present the variables (predictors) with significant coefficients. Among all other predictors 
such as effectiveness, ease of use or satisfaction level scores patients provided, number of reviews (volume) 
is the only significant variable that affect the prediction of medication prescription amounts. Comparing 
to model 1, model 2 includes yzs	
O{?|r7}vz7 as additional predictor and achieves lower MSE and 
both better R  and adjusted 	R . However, based on the results presented in table 9, 
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yzs	
O{?|r7}vz7	is not significantly affecting the prescription prediction results. Satisfy (satisfaction 
level score) in model 2, on the other hand, turns to be a significant predictor. Model 3 includes extra 
network structure based predictors such as PageRank and weighted PageRank. Besides significant 
predictor NumReview, weighted PageRank plays a significant role in prediction as well. Last but not the 
least, by further inserting the predictor yzs
K that is from ATIO system in our model 4, not only yzs
K is 
significant, but predictors such as satisfy, NumTransition and weighted PageRank turn significant as well.  
Conclusion  
Medication prescription demands and rankings prediction are challenging tasks that rely highly on 
historical prescription demands and user data. By integrating both text mining techniques and network 
analysis, our study identifies the important predictive power of medication relations, that have not been 
analyzed before, for prescription changes and rankings forecasting. Medication switch and combination 
are common actions among patients and frequent medication switching and combination behavior could 
serve as an influential indicator for prescription demand changes and competition detection. However, 
the medication switching sequences and combination records are difficult to access without patients’ full 
prescription history. To predict the medication prescription rankings with medication relation network, 
our study first aims at discovering the medication transition and combination patterns from unstructured 
patient generated contents. We construct two supervised SVM systems for identifying medication 
references and categorizing transition and combination relations from reviews. We further draw directed 
network based on medication transition relations and undirected network for combination relations. After 
transforming the network to transition probability matrix, we propose ATIO system for medication 
prescription rankings prediction. The proposed method suggests significant strongest negative correlation 
with the actual rankings and positive influence on the actual prescription demands. Other transition and 
combination network-based measures such as PageRank, weighted PageRank and HITS authority also 
demonstrate significant negative correlations with the actual rankings. Furthermore, we employ 
predictive regressions for percentage of prescription changes prediction. The predictive model 
incorporating the measure from ATIO system as one of the predictors achieves the least MSE and the 
highest R and adjusted R.  
Besides the academic value shown here, the transition and combination network as a construct also 
provides important practical implications for pharmaceutical companies and medication consumers. 
Besides employing the network for rankings and demands prediction, it is easier to recognize the most 
competitive brands for one medication by inspecting the transition network. Through examining the 
transition probability of the focal medication to its STMs, companies could consider the STMs with the 
highest transition probability as the most comparative product. This STM product would threat the 
demands of the focal medication the most. After detecting the competitions, pharmaceutical companies 
could adopt respective strategies such as better marketing promotions or change of the formula so as to 
gain back the customers. On the other hand, if pharmaceutical companies identify the TCMs for their 
focal medications, they could design better marketing strategies by promoting the TCM and focal 
medication as a bundle. Similarly, by inspecting the MRN, medication consumers could identify the 
alternatives of their medication. Customers could recognize and learn STMs with highest transition 
probability and treat them as comparative candidates for switching if they are not completely satisfied 
with their current focal medication.  
Furthermore, in addition to clinical predictions, the transition and combination network can be applied to 
support important predictions and analysis in other domains. The network could serve as a good decision-
support tool for business executives. Customers who purchase and consume merchandises such as beauty, 
pet or baby products would normally need to re-fill their orders in a time interval. Some of them are 
willing to try different products fulfilling the same need. For example, after customer finished one 
shampoo brand, he or she might be willing to try another brand. In addition, shampoo and conditioner 
are always purchased together. These transition and combination behavior for consumable merchandises 
are very common and are also reflected in the user generated reviews. By constructing transition and 
combination network using customers’ reviews, business executives could not only recognize their 
competitions, but also use the network structure as an important feature to predict the merchandise sales 
and rankings. Existing marketing research seems to focus on brand switching and often use different 
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models such as Bayesian learning model (Erdem and Keane 1996). We could learn from these models and 
compare the performance of our model with the current models in our future study.  
However, our study also suffers from a few limitations. We highlight several important ones and potential 
future work in the following. First of all, we only annotated 200 medication reviews from WebMD for 
medication reference identification and relation classification models building and evaluation. The data 
sparsity problem would affect our model performance and the further network learning. In addition, 
WebMD is the only forum we extracted reviews and discussions from, multiple data sources such as 
AskPatient.com and MedHelp would increase the review volume and also the generality of patients. It is 
therefore important to extend the variety of data source and increase number of annotated reviews.   
Secondly, we were able to predict rankings for year 2009, 2011 and 2013 since IMS health only reveal 
yearly rankings and prescription amounts for psychiatric medications. Monthly rankings and prescription 
quantities in the future would motivate accurate and dynamic prediction results. Thirdly, we did not focus 
on establishing causal relationships in the current study. Due to data limitations, we have little 
information about the important factors such as marketing strategies or patient and physician incentives. 
The inaccessible of these missing variables prevents us from building causality-based models. Future 
work in this direction could involve medication transition and combination metrics for differentiating 
medications and focus on causality-based demand system building. We could further extract the time 
point of direct switching behavior to answer questions, such as when patients would transit and how long 
patients could stay on certain medication, because our direct transition is counted from text mining 
results of review contents. For example, for the time duration of direct transition, we could track certain 
patient’s other medication reviews and check if they stopped the other medication again and how long is 
the time duration. However, indirect transition is estimated based on probability derivate from the 
network structure and the duration of each transition is difficult to track. Our method therefore is limited 
in recognizing the time span of staying on the transited medications. 
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